As per Zion Market Research, the global hemodialysis vascular grafts market was capitalized at USD 310 million in 2019 and is predicted to develop at a CAGR of 5.2% during 2020-2026. Increasing acceptance of biological access grafts, rising occurrence of renal disorders, and technical innovations in these goods are some of the reasons predicted to power the market growth over the years to come.
The global market is dominated by few players such as C. R. Bard, Inc.; W.L. Gore & Associates; LeMaitre Vascular, Inc.; Terumo Medical Corporation; and Getinge AB. Other players active in the market are InnAVasc Medical, Inc.; Vascular Genesis; Merit Medical Systems, Inc.; CryoLife, Inc.; and Proteon Therapeutics, Inc.
Rising Awareness About CKD In Developing Nations To Power The Market Growth
Restricted kidney donors’ availability is resulting in a rise in the number of users with CKD (chronic kidney disease) opting for hemodialysis. Consequently, the requirement for hemodialysis vascular grafts is predicted to see an upswing in the years to come.
Developing nation have huge unmet population going through CKD, owing to moderately poor healthcare facilities, late diagnosis, existence of cost-sensitive patient pool, and unavailability of suitable kidney donors. Therefore, kidney transplantation operation has less inclination in comparison to hemodialysis operation in developing nations, due to existence of affordable options such as vascular access grafts.
Rising awareness about CKD in these nations is expected to power the market growth in the years to come. For example, India Renal Foundation is a private agency comprised in performing awareness initiative for avoiding kidney diseases. The agency has performed almost 15,000 initiatives so far.
North America Added Up For The Biggest Income Share In 2019 In The Global Market
Patients suffering from dialysis should get long-term central venous catheterization, whereas they also have another option of AVG (arteriovenous graft). This AVG is employed in case, where all exterior veins of users are exhausted owing to continuous procedure of hemodialysis. Even though synthetic PTFE (polytetrafluoroethylene) grafts are turning out to be popular all over the world, they have various drawbacks such as high risk of infection, steal syndrome, and long patency. In comparison to synthetic, biological access grafts have elevated patient advantages such as fewer chances of rejections and reduced danger of infection.
North America added up for the biggest income share in 2019 in the global market. Higher healthcare spending as an amount of GDP, higher inclination for tissue and biological engineered vascular access grafts, and elevated number of users with CKD are amongst the primary major growth factors for the market.
Request for Custom Research @ https://www.zionmarketresearch.com/custom/3942/news
The global hemodialysis vascular grafts market is segmented as follows:
By Raw Material
- Biological Materials
- North America
- The U.S.
- The UK
- Rest of Europe
- Asia Pacific
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa
Make an enquiry of this report @ https://www.zionmarketresearch.com/buynow/su/hemodialysis-vascular-grafts-market/news
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651